Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist developed to improve blood sugar control and support weight loss. It mimics two natural gut hormones that regulate insulin secretion and appetite. By enhancing insulin sensitivity and slowing gastric emptying, it helps reduce glucose spikes after meals. Clinical studies have shown significant fat loss and improved metabolic health in both diabetic and non-diabetic individuals. Tirzepatide also reduces cravings and promotes a feeling of fullness. Overall, it is a powerful metabolic peptide that enhances glucose control, fat reduction, and appetite regulation.